Mission Mission

Mission

Change how medicines are tested in animals and humans by building agentic systems accurate enough to end unexpected drug toxicity.

Mission

90% of drug candidates fail in clinical development because existing tests do not reliably predict human outcomes.

Mission

We want to build agents accurate enough to dramatically improve the success rate of drug development.

Mission

Who we serve

Dominique Bonafoux

Dominique Bonafoux

VP of Small Molecule Chemistry

"I want to develop medicines safe enough that I would give them to my own family without hesitation. That, to me, is the standard we should hold ourselves to in drug discovery: not simply advancing compounds that show promise, but building the evidence and confidence that they are truly safe for patients in the real world. This remains an immense challenges which existing approaches have been unable to solve."

LinkedIn
Nicholas Meanwell

Nicholas Meanwell

VP of Medicinal Chemistry

"Despite advances in screening methods, biochemical understanding and a broader awareness of toxicophores, toxicity persists as one of the main causes of drug attrition both preclinically and clinically with hepatotoxicity a particularly difficult challenge. There remains a pressing need for better tools to predict toxicity and a deeper understanding of the underlying mechanisms."

LinkedIn
Yvonne Will

Yvonne Will

Founder

"Early safety decisions often fail not due to lack of data, but lack of decision-ready insight. Platforms like Axiom shift the focus from binary hazard flags to mechanistic, exposure-aware risk understanding. This enables teams to distinguish manageable signals from true liabilities—earlier in discovery, when it matters most. The result: better compound selection, fewer late-stage surprises, and more confident decisions."

LinkedIn

Axiom's Digest

Learn more about our work

Understand drug toxicity before it reaches humans.